Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 62,987 shares at $110.26 ($6.9M) on 2018-11-07, disclosed to the SEC on 2018-11-08.
Open-market sale of $6.9M NBIX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.10 | 9,420 | $1.0M | 14.9% |
| 2 | $110.00 | 5,231 | $575K | 8.3% |
| 3 | $110.03 | 9,122 | $1.0M | 14.5% |
| 4 | $110.03 | 9,122 | $1.0M | 14.5% |
| 5 | $110.26 | 15,046 | $1.7M | 23.9% |
| 6 | $110.26 | 15,046 |
| $1.7M |
| 23.9% |
| Total | $110.15 avg | 62,987 | $6.9M | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $537K | — | Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |